Cargando…

The involvement of Bcl-2 family proteins in AKT-regulated cell survival in cisplatin resistant epithelial ovarian cancer

Many studies involving patients with cisplatin-resistant ovarian cancer have shown that AKT activation leads to inhibition of apoptosis. The aim of this study was to examine the potential involvement of the Bcl-2 family proteins in AKT-regulated cell survival in response to cisplatin treatment. Cisp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Yan, Jin, Shiguang, Li, Xueping, Wang, Daxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352061/ https://www.ncbi.nlm.nih.gov/pubmed/27935869 http://dx.doi.org/10.18632/oncotarget.13817

Ejemplares similares

Correction: The involvement of Bcl-2 family proteins in AKT-regulated cell survival in cisplatin resistant epithelial ovarian cancer
por: Dai, Yan, et al.
Publicado: (2020)

Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT
por: Huang, Genhua, et al.
Publicado: (2019)

NTNG1 Modulates Cisplatin Resistance in Epithelial Ovarian Cancer Cells via the GAS6/AXL/Akt Pathway
por: Fang, Shanyu, et al.
Publicado: (2021)

Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance
por: Leisching, Gina, et al.
Publicado: (2015)

The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
por: Wu, Wei, et al.
Publicado: (2014)

Upregulation of Fas in epithelial ovarian cancer reverses the development of resistance to Cisplatin
por: Yang, Fan, et al.
Publicado: (2015)

Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance
por: Leung, E L, et al.
Publicado: (2008)

β-catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl
por: ZHANG, JIN, et al.
Publicado: (2016)

BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma
por: Beale, P J, et al.
Publicado: (2000)

8-bromo-7-methoxychrysin induces apoptosis by regulating Akt/FOXO3a pathway in cisplatin-sensitive and resistant ovarian cancer cells
por: DING, QING, et al.
Publicado: (2015)

Activation of hedgehog signaling and its association with cisplatin resistance in ovarian epithelial tumors
por: Song, Xueling, et al.
Publicado: (2018)

EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells
por: Poursheikhani, Arash, et al.
Publicado: (2020)

Retraction: The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
por: Wu, Wei, et al.
Publicado: (2020)

Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux
por: Zhao, Yujie, et al.
Publicado: (2021)

ROS-Induced DCTPP1 Upregulation Contributes to Cisplatin Resistance in Ovarian Cancer
por: Wang, Yu, et al.
Publicado: (2022)

BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin
por: Bansal, Nisha, et al.
Publicado: (2012)

Esomeprazole Alleviates Cisplatin Resistance by Inhibiting the AKT/mTOR Pathway in Ovarian Cancer Cells
por: Duan, Jingya, et al.
Publicado: (2023)

Regulation of AKT gene expression by cisplatin
por: ZHANG, JUN, et al.
Publicado: (2013)

TAZ Regulates the Cisplatin Resistance of Epithelial Ovarian Cancer Cells via the ANGPTL4/SOX2 Axis
por: Li, Caihong, et al.
Publicado: (2022)

hMOF induces cisplatin resistance of ovarian cancer by regulating the stability and expression of MDM2
por: Cai, Mingbo, et al.
Publicado: (2023)

Nicotine increases the resistance of lung cancer cells to cisplatin through enhancing Bcl-2 stability
por: Nishioka, T, et al.
Publicado: (2014)

Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin
por: Cai, J, et al.
Publicado: (2013)

Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells
por: Moraya, Amani I., et al.
Publicado: (2017)

Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer
por: Kim, Myung Joo, et al.
Publicado: (2012)

Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors
por: Chowanadisai, Winyoo, et al.
Publicado: (2016)

Small-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells
por: Wang, Haixia, et al.
Publicado: (2015)

TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling
por: Roberts, Cai M., et al.
Publicado: (2016)

Mitochondrial Involvement in Cisplatin Resistance
por: Cocetta, Veronica, et al.
Publicado: (2019)

Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes
por: Teng, P-N, et al.
Publicado: (2014)

Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells
por: Luo, Yanwei, et al.
Publicado: (2020)

MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
por: Moghbeli, Meysam
Publicado: (2021)

Regulation of MYB mediated cisplatin resistance of ovarian cancer cells involves miR-21-wnt signaling axis
por: Zhang, Xue-yan, et al.
Publicado: (2020)

Role of Bcl-2 Family Proteins in Photodynamic Therapy Mediated Cell Survival and Regulation
por: Aniogo, Eric Chekwube, et al.
Publicado: (2020)

Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathway
por: WANG, TIAN, et al.
Publicado: (2014)

Lanthanum Chloride Sensitizes Cisplatin Resistance of Ovarian Cancer Cells via PI3K/Akt Pathway
por: Fang, Shanyu, et al.
Publicado: (2021)

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
por: Lee, Erinna F., et al.
Publicado: (2019)

MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition
por: Cao, Lanqin, et al.
Publicado: (2018)

Acylated Ghrelin Renders Chemosensitive Ovarian Cancer Cells Resistant to Cisplatin Chemotherapy via Activation of the PI3K/Akt/mTOR Survival Pathway
por: El-kott, Attalla Farag, et al.
Publicado: (2019)

PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer
por: Risnayanti, Chitra, et al.
Publicado: (2018)

Downregulation of ITIH3 contributes to cisplatin-based chemotherapy resistance in ovarian carcinoma via the Bcl-2 mediated anti-apoptosis signaling pathway
por: Liu, Yingzhao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_umm0bjh8fu3sgd4bmbvlamu8fs